Haemonetics Corp. buy Citigroup Inc.
Start price
09.07.25
/
50%
€65.00
Target price
09.07.26
€76.78
Performance (%)
-29.54%
Price
28.08.25
€45.60
Summary
This prediction is currently active. The prediction for Haemonetics Corp. disappoints with a performance of -29.54%. This prediction currently runs until 09.07.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -3.390% | -3.390% |
| iShares Core DAX® | -1.740% | -1.152% |
| iShares Nasdaq 100 | -0.157% | -0.813% |
| iShares Nikkei 225® | -1.705% | 3.309% |
| iShares S&P 500 | 0.148% | 0.240% |
Comments by Citigroup_Inc_ for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat